IN GENERAL oestrogen receptor (RE) and progesterone receptor (RP) tend to occur together in breast carcinomas, RP being a marker of RE integrity (Horwitz et al., 1975a). It has also been claimed that RP is associated with a lower risk of distant metastatic spread (Pichon et al., 1980 (Thorsen, 1981) that heparin may interfere with the estimation of RP in vitro. It has further been shown (Hartveit, 1981) Material from the primary tumours had been taken at the time of operation, and divided, one part being used for receptor determination, one for histology. Both receptors were analysed by dextrancharcoal assay (DCA) (McGuire et al., 1975; Horwitz et al., 1975b) . Although cytosols were no longer available, a total of 186 paired samples (i.e. RE and RP values and the corresponding histological material) were.
IN GENERAL oestrogen receptor (RE) and progesterone receptor (RP) tend to occur together in breast carcinomas, RP being a marker of RE integrity (Horwitz et al., 1975a) . It has also been claimed that RP is associated with a lower risk of distant metastatic spread (Pichon et al., 1980) . The starting point for this work was a small group of tumours that seemed to deviate from this general rule; RP-and RE+. It has been shown (Thorsen, 1981) that heparin may interfere with the estimation of RP in vitro. It has further been shown (Hartveit, 1981) Material from the primary tumours had been taken at the time of operation, and divided, one part being used for receptor determination, one for histology. Both receptors were analysed by dextrancharcoal assay (DCA) (McGuire et al., 1975; Horwitz et al., 1975b) . Although cytosols were no longer available, a total of 186 paired samples (i.e. RE and RP values and the corresponding histological material) were.
From this material we selected all the RP-RE-cases (17), all the RP-RE+ (18) and the first 29 of the RP+ RE+. Values > 3 fmol/mg cytosol were considered positive for RE, > 5 fmol for RP. The age of the patients ranged from 33 to 91 years with a mean of 64. Only 9 of them were under 55. There was no difference in age distribution between the groups.
Sections from the formalin-fixed paraffin-embedded blocks from the primary tumours were stained with toluidine blue at pH4 (Hartveit, 1981) . The mast cells were counted at the edge of the tumour (in the zone of host-tumour interaction) using light microscopy (x 400). The microscope was connected to a digitizer (Summagraphic: Bit pad one) which in turn was connected to a computer, as described previously (Thoresen et al., 1982) . One slide was used per case and the total number of mast cells in 20 fields was counted.
The mean values ( s.d.) for the mastcell count were related to the receptor profile of the tumours, as judged from cytosol assay. The profile RP+ RE-is not included, as we had only 3 such cases.
The figure shows the range and distribution of the mast-cell counts in the Heparin is one of the main products of mast cells, and it has been claimed that they are the only source of this substance. It has further been shown that there is good correlation between the mast-cell content of a particular tissue and the amount of heparin that can be extracted from it (Holmgren et al., 1937; Jorpes, 1937) .
The reported frequency of specific progesterone receptor in human breast carcinoma varies from -40% (Skinner et al., 1980) to 60% (Horwitz etal., 1975a) . In our material it is 55%0 (Thorsen, unpublished) .
In keeping with the theory that the synthesis of RP depends on the action of oestrogen, Horwitz et al. (1 975a) found that RP+ tumours showed a higher frequency of regression after endocrine therapy than their RP-counterparts. Accordingly, the presence of RP may give a more accurate indication of a tumour's potential response to endocrine therapy than the presence of RE alone, though RP-tumours sometimes respond (Barnes et al., 1977) .
When heparin is added to tumour cytosol containing RP suppression of the binding of R5020 occurs in the DCA (Thorsen, 1981) . On the basis of the high mast-cell counts in the RP-RE+ samples, the negative RP values may thus be false negatives, a result of the action of the indigenous heparin rather than lack of RP. The low mast-cell counts in the RP-REcytosols indicate that the RP-results may be acceptable on the face values, i.e. that the tumours really do lack RP. This would be in keeping with the previously stressed interdependence of RE and RP.
A further possible source of falsenegative results is a low level of circulating oestrogen, with subsequent failure to generate RP. King (1980) found that postmenopausal women had a higher proportion of RP-tumours than premenopausal women, and explained this on the basis of low oestrogen levels in the former. But Lesser et al. (1981) found no significant variation with menstrual status, in keeping with the findings from 270 cases investigated here (Thorsen, unpublished) .
The lack of correlation between the actual RP values and the mast-cell counts stress that no quantitative assessment can be given. This is in keeping with lack of correlation between the actual RE values and other parameters (Thoresen et al., 1981) .
The present work suggests that due account should be taken of the tumour mast-cell content before a negative RP report is accepted. Patients with tumours with a RP-RE+ profile could theoretically react favourably to endocrine therapy. It will also be necessary to differentiate carefully between the groups RP-, REand RP-RE+ before any prognostic significance is attached to the absence of RP. Finally, the possibility that the prognostic significance attached to lack of RP (Pichon et al., 1980) should rather be attributed to the tumour mast-cell content cannot be dismissed, but needs further evaluation that is outside the scope of the present paper.
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